Microbiomes – News and Features
Manipulating the Microbiome Could help Manage Weight
UChicago researchers team was able to unravel some of the mechanisms that regulate this weight gain.
Inflammation Drives Crohn's Disease, Says Study
Recent studies show marked changes in the composition of the intestinal bacteria in people with CD.
Bacteria on Skin Boost Immune Cell Function
The findings provides new insights into skin health.
(1)H NMR-Based Metabolite Profiling of Diet-Induced Obesity in a Mouse Mode
In this study researchers demonstrate how the metabolic effects of high carbohydrate diets and high fat diets relate to the mechanism of diet-induced obesity and its associated complications.
Mapping the Healthy Human Microbiome
Broad scientists create molecular tools and applying standardized protocols, generating vast amounts of data to identify the microbiome's most elusive organisms for whole genome sequencing.
NIH Human Microbiome Project Defines Normal Bacterial Makeup of the Body
Genome sequencing creates first reference data for microbes living with healthy adults.
Real Time Genomics Appoints Steve Lombardi as CEO
Genomics industry veteran will drive commercialization of the company’s highly scalable core technology for next generation genomic analysis.
J. Craig Venter, Ph.D., Describes Biofuels, Vaccines and Foods from Made-to-Order Microbes
Scientists are using decades of knowledge garnered from sequencing or “reading” the genetic codes of thousands of living things to now start writing new volumes in the library of life.
Ritter Completes Phase 2 Clinical Study of RP-G28 for the Treatment of Lactose Intolerance
Company expects to announce phase 2 clinical data in first quarter of 2012.
Ritter Pharmaceuticals Completes Phase 2 Clinical Study for the Treatment of Lactose Intolerance
Ritter Pharmaceuticals, Inc. (Ritter) announced the last patient has completed treatment in its Phase 2 study for RP-G28, a first-in-class treatment for symptoms associated with lactose intolerance.